Feline chronic pain management has advanced significantly with new drug classes, recognition tools and multimodal approaches that improve quality of life for cats with arthritis and other painful conditions.
Feline chronic pain management welfare has been transformed by availability of targeted analgesics with better safety profiles than traditional NSAIDs. The previous situation - cats with chronic pain but limited safe medication options, leading to undertreated pain - has improved significantly. Frunevetmab in particular offers once-monthly injection by the veterinarian, eliminating the owner compliance challenge of daily pilling and the cat welfare cost of repeated oral medication. Multimodal approaches that combine appropriate analgesia with physical rehabilitation, environmental adaptation and owner education about pain recognition produce the best welfare outcomes - addressing pain at multiple levels rather than relying on medication alone.